Senate Bill 3394
117th Congress(2021-2022)
Emergency Use Transparency Act
Introduced
Introduced in Senate on Dec 14, 2021
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
3394
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No Senate votes have been held for this bill.
Summary
Emergency Use Transparency Act
This bill expands existing statutory provisions requiring the Food and Drug Administration (FDA) to publish notices of authorizations, terminations, or revocations of emergency use authorizations for medical products.
Specifically, the bill requires the FDA to publish such notices on its website. The bill also allows the FDA's disclosures to include a summary of data or information from additional types of submissions.
December 14, 2021
Sort by most recent
12/14/2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
12/14/2021
Introduced in Senate
Public Record
Record Updated
Dec 30, 2022 3:34:01 AM